[Zinc as the therapy of choice in acrodermatitis enteropathica].
D000085:Acetates; D000169:Acrodermatitis / Q000188:drug therapy* / Q000209:etiology; D000818:Animals; D001682:Biological Availability; D002104:Cadmium / Q000037:antagonists & inhibitors; D002417:Cattle; D002418:Cattle Diseases / Q000209:etiology; D002675:Child, Preschool; D005260:Female; D005942:Gluconates; D006801:Humans; D007223:Infant; D008297:Male; D008664:Metal Metabolism, Inborn Errors / Q000150:complications; D009461:Neurologic Manifestations; D010241:Parakeratosis / Q000188:drug therapy / Q000209:etiology / Q000662:veterinary; D013431:Sulfates; D015032:Zinc / Q000008:administration & dosage / Q000172:deficiency / Q000502:physiology / Q000627:therapeutic use*; D015034:Zinc Oxide / Q000627:therapeutic use
D000085:Acetates; D005942:Gluconates; D013431:Sulfates; D002104:Cadmium; D015032:Zinc; D015034:Zinc Oxide
Zink als Therapie der Wahl bei Acrodermatitis enteropathica